Detail akcie MBody AI Ltd online

Business Summary: Check-Cap Ltd. is an Israel-based clinical-stage medical diagnostics company focused on colorectal cancer (CRC) screening solutions. The Company develops C-Scan, a preparation-free and non-invasive screening system designed to detect precancerous polyps and structural abnormalities in the colon. Its technology uses an ingestible capsule with ultra-low-dose X-ray imaging to scan the colon and collect diagnostic data. The C-Scan platform consists of an ingestible capsule, body-worn tracking and data collection components, and proprietary software that processes information and generates visual maps of the colon. The Company develops diagnostic technologies for gastrointestinal screening and early disease detection.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Check Cap Ltd revenues was not reported. Net income totaled $4.1M vs. loss of $25.1M. Net income reflects Impairment of loans receivable decrease from $16.5M (expense) to $0K, General and Administrative Expenses decrease of 76% to $2M (expense), Expenses for employee benefits decrease of 75% to $200K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$30.0973 to $4.64993.